Organigram Holdings Inc.

OGI

CA68620P7056

Healthcare Facilities & Services

Market Closed - Toronto S.E. Other stock markets 21:00:00 31/05/2024 BST			5-day change	1st Jan Change
2.34 ^CAD	-0.43%		-5.65%	+36.05%

05-28	Organigram Signs Three-Year Supply Agreement With Avida Medical in UK	MT
05-28	Organigram to Supply U.K.'s Avida Medical With Dried Cannabis Flower in Three-Year Deal	MT

OrganiGram Holdings Inc. Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022

April 12, 2022 at 11:00 am

OrganiGram Holdings Inc. provided revenue guidance for the third quarter of fiscal year 2022. The company currently expects third fiscal 2022 revenue to be higher than second quarter fiscal 2022.

Latest news about Organigram Holdings Inc.

Organigram Signs Three-Year Supply Agreement With Avida Medical in UK	05-28	MT
Organigram to Supply U.K.'s Avida Medical With Dried Cannabis Flower in Three-Year Deal	05-28	MT
Organigram Brief: Says Signed Three Year Supply Agreement with Avida Medical in UK	05-28	MT
Organigram Signs Three Year Supply Agreement with Avida Medical in UK	05-28	CI
Toronto Stocks Edge Down; Hudbay Minerals Rises on 1Q Earnings Beat	05-14	DJ
Transcript : Organigram Holdings Inc., Q2 2024 Earnings Call, May 14, 2024	05-14
Organigram Fiscal Q2 Loss Surges as Revenue Falls 5%	05-14	MT
Organigram Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-14	CI
Organigram Brief: Q2 Fiscal 2024 Net loss was $27.1 million compared to $7.5 million in Q2 Fiscal 2023	05-14	MT
Organigram Brief: Q2 Fiscal 2024 overall net revenue decreased 5% to $37.6 million, from $39.5 million in Q2 Fiscal 2023	05-14	MT
Organigram Brief: Q2 Fiscal 2024 recreational net revenue increased 21% to $33.1 million from $27.4 million in the second quarter ended February 28, 2023	05-14	MT
North American Morning Briefing : Powell Comments, -2-	04-16	DJ
Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral	04-15	MT
Organigram Holdings Completes Underwritten Public Offering	04-02	MT
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot	04-02	MT
Organigram Reports Overnight Marketed Public Offering; Down Over 19%	03-27	MT
Organigram Reports Overnight Marketed Public Offering	03-27	MT
Organigram Reports Minority Investment in Open Book Extracts; Up 8.8%	03-26	MT
Organigram Up 2.2% In US Premarket After Receiving Health Canada's Final Redetermination on Jolts	03-25	MT
Organigram Holdings Inc. Receives Health Canada?S Final Redetermination on Jolts	03-22	CI
Organigram Notes The Standing Committee on Finance's Recommendation on Excise Duty	02-28	MT
Organigram Swings to Loss in Fiscal Q1, Net Revenue Falls; Provides Outlook; Down Over 13%	02-13	MT
Transcript : Organigram Holdings Inc., Q1 2024 Earnings Call, Feb 13, 2024	02-13
Organigram Swings to Loss in Fiscal Q1, Net Revenue Falls; Provides Outlook	02-13	MT
Organigram Holdings Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-13	CI

Chart Organigram Holdings Inc.

Duration

Period

More charts

Organigram Holdings Inc. operates through its subsidiaries. The Companyâs major wholly owned subsidiaries include Organigram Inc., 10870277 Canada Inc., The Edibles and Infusions Corporation (EIC), and Laurentian Organic Inc. (Laurentian). Organigram Inc. is a licensed producer (LP) of cannabis, cannabis-derived products and cannabis infused edibles in Canada. It is focused on producing cannabis for patients and adult recreational consumers, as well as developing international business partnerships. It has also developed and owns a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag Oâ Buds, SHRED, SHREDâems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. 10870277 Canada Inc. is a special purpose holding company for the Company. EIC is a cannabis processor of confectionary goods.

Sector

Healthcare Facilities & Services

Calendar

10/07/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Organigram Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.34 CAD

Average target price

3.629 CAD

Spread / Average Target

+55.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
ORGANIGRAM HOLDINGS INC.	+36.05%	177M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
ASCEND WELLNESS HOLDINGS, INC.	+10.31%	228M
INTERCURE LTD.	+141.20%	137M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
JUSHI HOLDINGS INC.	+32.61%	120M
THE CANNABIST COMPANY HOLDINGS INC.	-47.02%	109M
4FRONT VENTURES CORP.	-.--%	87.2M
BAKHU HOLDINGS, CORP.	+150.00%	75.33M

Medical Farming